AVAH on Nasdaq
Aveanna Healthcare Holdings, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Chemed Corporation, AdaptHealth Corp. or Addus HomeCare Corp, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Private Duty Services brought in 82% of the revenue Aveanna Healthcare Holdings, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Private Duty Services | $1.6B | $2.0B |
| Home Health And Hospice | $217.8M | $248.6M |
| Medical Solutions | $172.1M | $183.5M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Selling, general and admin15¢$374.5M
- Other costs65¢$1.6B
- Interest6¢$140.1M
- Income tax5¢$118.1M
- Profit9¢$225.0M
Out of $2.4B in revenue.2
Where each dollar of operating cash went, fiscal 2026
- Kept or used elsewhere100¢$125.9M
Out of $125.9M of cash from operations.2
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $2.4B | $2.0B |
| Cost of revenue, excluding depreciation and amortization | $1.6B | $1.4B |
| Branch and regional administrative expenses | $374.5M | $352.8M |
| Corporate expenses | $163.3M | $125.4M |
| Depreciation and amortization | $10.5M | $10.8M |
| Acquisition-related costs | $3.8M | $1.5M |
| Other operating expense | $1.9M | $5.3M |
| Operating income | $256.5M | $139.8M |
| Interest income | $2.8M | $498.0K |
| Interest expense | -$140.1M | -$156.6M |
| Loss on debt extinguishment | -$5.9M | $0 |
| Other (expense) income | -$6.4M | $21.4M |
| Income before income taxes | $106.9M | $5.1M |
| Income tax benefit (expense) | $118.1M | -$16.0M |
| Net income (loss) | $225.0M | -$10.9M |
| Net income (loss) per share, basic | $1.11 | -$0.06 |
| Weighted average shares of common stock outstanding, basic | 203.5M shares | 192.9M shares |
| Net income (loss) per share, diluted | $1.05 | -$0.06 |
| Weighted average shares of common stock outstanding, diluted | 215.0M shares | 192.9M shares |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $193.3M | $84.3M | |
| Patient accounts receivable | $313.4M | $265.2M | |
| Receivables under insured programs | $2.8M | $12.5M | |
| Prepaid expenses | $20.9M | $17.5M | |
| Other current assets | $29.9M | $13.2M | |
| Total current assets | $560.2M | $392.7M | |
| Property and equipment, net | $16.7M | $17.4M | |
| Operating lease right of use assets | $39.0M | $41.3M | |
| Goodwill | $1.1B | $1.1B | $1.1B |
| Intangible assets, net | $92.6M | $89.6M | |
| Receivables under insured programs | $28.8M | $22.4M | |
| Deferred income taxes | $137.1M | ||
| Other long-term assets | $16.9M | $45.5M | |
| Total assets | $2.0B | $1.7B | |
| Accounts payable and other accrued liabilities | $32.0M | $36.4M | |
| Accrued payroll and employee benefits | $108.1M | $87.7M | |
| Current portion of insurance reserves - insured programs | $2.8M | $12.5M | |
| Current portion of insurance reserves | $17.2M | $18.4M | |
| Securitization obligations | $165.0M | $168.8M | |
| Current portion of long-term obligations | $13.2M | $9.2M | |
| Current portion of operating lease liabilities | $16.0M | $15.5M | |
| Other current liabilities | $70.2M | $53.7M | |
| Total current liabilities | $424.5M | $402.2M | |
| Long-term obligations, less current portion | $1.3B | $1.3B | |
| Long-term insurance reserves - insured programs | $28.8M | $22.4M | |
| Long-term insurance reserves | $49.1M | $44.5M | |
| Operating lease liabilities, less current portion | $27.4M | $31.7M | |
| Deferred income taxes | $5.9M | ||
| Other long-term liabilities | $800.0K | $7.1M | |
| Total liabilities | $1.8B | $1.8B | |
| Deferred restricted stock units | $730.0K | $1.5M | |
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 210,996,359 and 193,225,177 issued and outstanding, respectively | $2.1M | $1.9M | |
| Additional paid-in capital | $1.3B | $1.3B | |
| Accumulated deficit | -$1.2B | -$1.4B | |
| Total stockholders' equity (deficit) | $194.5M | -$123.6M | -$129.6M |
| Total liabilities, deferred restricted stock units, and stockholders' equity (deficit) | $2.0B | $1.7B | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, authorized | 5.0M shares | 5.0M shares | |
| Preferred stock, issued | 0 shares | 0 shares | |
| Preferred stock,outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, authorized | 1.0B shares | 1.0B shares | |
| Common stock, issued | 211.0M shares | 193.2M shares | |
| Common stock, outstanding | 211.0M shares | 193.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $225.0M | -$10.9M |
| Depreciation and amortization | $10.5M | $10.8M |
| Amortization of deferred debt issuance costs | $5.9M | $5.5M |
| Reduction in carrying amount of operating lease right of use assets | $17.7M | $20.4M |
| Non-cash share-based compensation | $25.1M | $17.5M |
| Loss on disposal or impairment of licenses, property and equipment, and software | $1.9M | $3.2M |
| Fair value adjustments on interest rate derivatives | $29.7M | $15.2M |
| Loss on debt extinguishment | $5.9M | $0 |
| Deferred income taxes | -$143.0M | $1.0M |
| Patient accounts receivable | -$30.2M | -$28.6M |
| Prepaid expenses | $6.5M | $6.0M |
| Other current and long-term assets | -$26.8M | -$20.6M |
| Accounts payable and other accrued liabilities | -$6.2M | $6.4M |
| Accrued payroll and employee benefits | $15.7M | $20.5M |
| Insurance reserves | $2.2M | $1.7M |
| Operating lease liabilities | -$19.3M | -$19.6M |
| Other current and long-term liabilities | $5.5M | $4.2M |
| Net cash provided by operating activities | $125.9M | $32.6M |
| Acquisitions of businesses, net of cash acquired | -$14.9M | $0 |
| Purchases of property and equipment, and software | -$7.4M | -$6.3M |
| Net cash used in investing activities | -$22.3M | -$6.3M |
| Payments for shares withheld to cover employee taxes on vesting of restricted stock | -$6.3M | $0 |
| Proceeds from exercise of options | $212.0K | $0 |
| Proceeds from employee stock purchase plan | $6.3M | $3.1M |
| Proceeds from securitization obligation | $0 | $25.0M |
| Repayment of securitization obligation | -$3.8M | -$11.2M |
| Proceeds from issuance of term loans, net of debt issuance costs | $1.3B | $0 |
| Principal payments on term loans | -$1.3B | -$9.2M |
| Principal payments on notes payable | -$8.9M | -$6.6M |
| Principal payments on financing lease obligations | $0 | -$267.0K |
| Payment of debt issuance costs | -$3.6M | -$2.2M |
| Settlements with interest rate swap counterparties | $12.6M | $15.5M |
| Net cash provided by financing activities | $5.4M | $14.0M |
| Net change in cash and cash equivalents | $109.0M | $40.3M |
| Cash paid for interest | $143.1M | $152.5M |
| U.S. Federal | $24.5M | |
| California | $2.9M | |
| Other State and Local | $3.4M | |
| Foreign | $0 | |
| Total Cash paid for income taxes, net of refunds received | $30.8M | $5.7M |
| Financed insurance premiums | $9.2M | $7.8M |
Compare Aveanna Healthcare Holdings, Inc. with another company
Recent filings
- Oct 5, 20264
- Oct 2, 20268-K
- Sep 9, 2026144
- Aug 27, 2026144
- Aug 24, 2026424B4
- Aug 24, 20268-K
- Aug 24, 20264
- Aug 24, 20264
- Aug 24, 20264
- Aug 24, 20264
- Aug 24, 20264
- Aug 24, 20264
- Aug 20, 2026424B4
- Aug 13, 20268-K
- Aug 13, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9